We are live on
!
Find out more
NSEDCP
NJ State Employees Deferred Compensation Plan Portfolio holdings
AUM
$906M
1-Year Est. Return
24.85%
This Fund
S&P 500
This Quarter
Est. Return
+8.53%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$648M
AUM Growth
+$29.8M
(+4.8%)
Cap. Flow
-$3.58M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
24.89%
Holding
504
New
21
Increased
6
Reduced
16
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$1.52M |
| 2 |
CMS Energy
CMS
|
+$1.35M |
| 3 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$1.27M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$955K |
| 5 |
Cenovus Energy
CVE
|
+$954K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travelers Companies
TRV
|
+$2.4M |
| 2 |
Chevron
CVX
|
+$1.93M |
| 3 |
Humana
HUM
|
+$1.33M |
| 4 |
MRSH
Marsh
MRSH
|
+$1.33M |
| 5 |
Prudential Financial
PRU
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.55% |
| 2 | Healthcare | 14.61% |
| 3 | Industrials | 11.82% |
| 4 | Financials | 11.13% |
| 5 | Consumer Discretionary | 8.25% |
Similar funds
IAM
BFS
MSAM
SAM
CP
EAM
HWM
BVDMP
NJ State Employees Deferred Compensation Plan's Q1 2023 Portfolio in Review
As of Q1 2023, NJ State Employees Deferred Compensation Plan held 504 positions worth $648M, up 4.8% from $618M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
NJ State Employees Deferred Compensation Plan's Q1 2023 filing shows 21 new, 6 increased, 16 reduced and 9 closed positions. Its largest new stake was Cigna: 5,200 shares worth $1.33M. The largest sale was Travelers Companies, an estimated $2.4M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
- NJ State Employees Deferred Compensation Plan's largest Q1 2023 buy was Cigna: 5,200 shares worth $1.33M.
- NJ State Employees Deferred Compensation Plan added most to Prometheus Biosciences, Inc. Common Stock in Q1 2023, an estimated $1.27M increase.
- NJ State Employees Deferred Compensation Plan's biggest Q1 2023 reduction was Travelers Companies, cutting an estimated $2.4M.
- NJ State Employees Deferred Compensation Plan fully exited South Jersey Industries, Inc. in Q1 2023, selling an estimated $746K.
- NJ State Employees Deferred Compensation Plan's ten largest holdings make up 25% of its $648M portfolio in Q1 2023.
- NJ State Employees Deferred Compensation Plan opened 21 new positions and closed 9 in Q1 2023.
- NJ State Employees Deferred Compensation Plan's portfolio value rose 4.8% quarter-over-quarter to $648M.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2023, filed 26 Apr 2023.